
Last weekend, I visited an acquaintance's home and noticed a small pill bottle on the dining table. It contained low-dose aspirin with half of the white pills remaining.
The elder mentioned that they have been taking it every morning for over ten years. They started taking it because someone recommended it for heart health, but recently they've been hearing conflicting advice about stopping, which has left them confused.
This comment lingered in my mind after I got home. So, I spent the evening researching, and today I want to calmly summarize what I found.
First, it's important to clarify that discussions about aspirin should completely separate individuals who have experienced a heart attack or stroke from those who have not.
For someone who has already had an event, taking aspirin to prevent a recurrence is referred to as secondary prevention. This is still considered an important treatment by doctors today, and it differs from what we will discuss.
The confusion arises when considering individuals who take aspirin for preventive purposes without having experienced any events, which falls under primary prevention. The pill bottle at the elder's home falls into this category.
The U.S. Preventive Services Task Force (USPSTF) released its final recommendations in April 2022. It stated that adults over 60 should not start low-dose aspirin for primary prevention, and it received a grade of D.
A grade D means that the risks outweigh the benefits or that there is no net benefit. The committee concluded with moderate certainty that starting aspirin in this age group does not provide a net benefit.
For those aged 40 to 59, if there is a 10% or greater risk of cardiovascular disease within the next ten years, a grade C recommendation suggests individual assessment. This does not mean to take it unconditionally but rather to discuss it with a doctor.
This was quite a significant shift. The 2016 recommendations advised some individuals in their 50s to start taking aspirin, so the guidance has changed in just a few years.
Why did it change? The key factor was bleeding.
Aspirin thins the blood to prevent clots but also increases the risk of bleeding in the stomach or brain. The committee noted that while this risk is generally small, it increases with age, particularly after 60.
A major study that influenced this decision was the ASPREE trial published in 2018. It compared low-dose aspirin to a placebo in healthy older adults in the U.S. and Australia.
I was honestly surprised by the results. There was no significant difference in cardiovascular events between the two groups, but major bleeding was more common in the aspirin group.
In numerical terms, major bleeding occurred at a rate of 8.6 per 1,000 person-years in the aspirin group compared to 6.2 in the placebo group. The primary outcome of living longer without disability also did not improve for those taking aspirin.
Reading this might make you feel like you should stop taking it immediately. However, I believe this is a moment to pause and reflect.
The USPSTF recommendations are about starting aspirin anew. The question of when and how to stop for someone who has been taking it for a long time is a separate issue.
There was a Swedish study published in the journal Circulation in 2017. It tracked over 600,000 people aged 40 and older who were prescribed low-dose aspirin, and it found that those who stopped had a 37% higher rate of cardiovascular events compared to those who continued taking it.
When looking specifically at those taking it for primary prevention, the difference was 28%. Of course, since this was an observational study, causation cannot be definitively established, and the researchers acknowledged this limitation.
Still, the message from this study is significant. Making a sudden decision to stop on your own can be risky.
The FDA has also expressed a similar stance since 2014. There is insufficient evidence to support daily aspirin for preventing the first heart attack or stroke in individuals who have not experienced cardiovascular issues.
At the same time, the FDA emphasizes that the decision regarding long-term use and dosage should be made by a doctor. Just because it is an easily accessible medication does not mean it should be taken lightly.
So, if you are currently taking aspirin, I encourage you to bring this question up at your next appointment. Discuss with your doctor or pharmacist why you started taking this medication and whether it is still appropriate for you to continue.
It's also helpful to prepare what you want to discuss in advance. Consider when you started taking it, whether you have experienced any gastrointestinal bleeding or easy bruising, and if you are taking any other blood thinners or pain relievers.
If explaining in English feels daunting, bringing the pill bottle with you can be a good strategy. Just showing the label can make the conversation much easier.
That day, I cautiously shared this information with the elder. Instead of telling them to stop, I simply suggested they ask about it at their regular check-up next month.
It seems that habits we start because they are beneficial may need to be reevaluated over time. This applies to both medications and lifestyle choices.
If it were me, I would choose to sit down with my medical history in front of my doctor rather than abruptly stopping out of fear. On that late autumn evening, that small pill bottle on the dining table left me with a heavy task to consider.

StarryMoon


fruitflash | 
Anjollinya Blog | 
United States Army | 
premium | 
The Emperor Must Grow | 
morninpo | 

breezem | 
silverleaf | 

MBTI Detective Agency |
ShyShy dating |
hihihi |
kiwifox |
Silent Sea |
Masa Masa |
dewyo |
summita |
coconutpath |
moonlight |
Dolly |
Curry Dragon |
secure |
tredon |
Eldorado 88 |
donggul donggul |
korvix |
Noodle Zin |
Forever Tiger Teacher |
strongman |